Prospective medicine: the role for genomics in personalized health planning

[1] BALABAN R, 2003, PHARMA TRENDS, V1, P2

[2] Bohm R., 2003, DUKE HEART FAILURE, P1

[3] Binge eating as a major phenotype of melanocortin 4 receptor gene mutations [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) : 1096 - 1103

[4] Carlson Bob, 2003, Manag Care, V12, P16

[5] Celebi Dogu, 2003, Healthc Inform, V20, P56

[6] Cohn JN, 1998, AM FAM PHYSICIAN, V57, P1901

[7] Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) : 538 - 549

[8] Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) : 1085 - 1095

[9] FREUDENHEIM M, NY TIMES C 0712, P1

[10] GOTTLIEB H, 2000, DRUG BENEFIT TRENDS, V12, P57

[1] BALABAN R, 2003, PHARMA TRENDS, V1, P2

[2] Bohm R., 2003, DUKE HEART FAILURE, P1

[3] Binge eating as a major phenotype of melanocortin 4 receptor gene mutations [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) : 1096 - 1103

[4] Carlson Bob, 2003, Manag Care, V12, P16

[5] Celebi Dogu, 2003, Healthc Inform, V20, P56

[6] Cohn JN, 1998, AM FAM PHYSICIAN, V57, P1901

[7] Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) : 538 - 549

[8] Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) : 1085 - 1095

[9] FREUDENHEIM M, NY TIMES C 0712, P1

[10] GOTTLIEB H, 2000, DRUG BENEFIT TRENDS, V12, P57